1315325-52-0

Upstream product

• 1315326-95-4 (2R,6S,13aS,14aR,16aS,Z)-6-amino-N-(cyclopropylsulfonyl)-5,16-dioxo-2-(2-(4-(trifluoromethyl)phenyl)-benzofuro[3,2-d]pyrimidin-4-yloxy)-1,2,3,5,6,7,8,9,10,11,13a,14,14a,15,16,16a-hexadecahydrocyclopropa[e]pyrrol-e[1,2-a][1,4]diazacyclopentadecine-14a-carboxamide hydrochloride 
• 1195976-53-4 C₄₃H₄₇F₃N₆O₉S 
• 1315326-71-6 (2S,4R)-N-((1R,2S)-1-(cyclopropylsulfonylcarbamoyl)-2-vinylcyclopropyl)-4-(2-(4-(trifluoromethyl)phenyl)benzofuro[3,2-d]pyrimidin-4-yloxy)pyrrolidine-2-carboxamide hydrochloride 
• 1315326-70-5 C₃₆H₃₆F₃N₅O₈S 
• 447433-47-8 2-(4-(trifluoromethyl)phenyl)benzofuro[3,2-d]pyrimidin-4(3H)-one 
• 54802-12-9 2-(2-cyanophenoxy)acetamide 
• 1315326-69-2 (2S,4R)-1-(tert-butoxycarbonyl)-4-(2-(4-(trifluoromethyl)phenyl)benzofuro[3,2-d]pyrimidin-4-yloxy)pyrrolidine-2-carboxylic acid 
• 1195977-21-9 tert-butyl (S)-1-((2S,4R)-2-(((1R,2S)-1-(cyclopropylsulfonylcarbamoyl)-2-vinylcyclopropyl)carbamoyl)-4-(2-(4-(trifluoromethyl)phenyl)benzofuro[3,2-d]pyrimidin-4-yloxy)pyrrolidin-1-yl)-1-oxonon-8-en-2-ylcarbamate 
• 1195977-16-2 4-chloro-2-(4-(trifluoromethyl)phenyl)benzofuro[3,2-d]pyrimidine 
• 898373-46-1 3-(4-(trifluoromethyl)benzamido)benzofuran-2-carboxamide 
• 1315326-96-5 (2R,6S,13aS,14aR,16aS,Z)-N-(cyclopropylsulfonyl)-5,16-dioxo-6-thioureido-2-(2-(4-(trifluoromethyl)phenyl)benzofuro[3,2-d]pyrimidin-4-yloxy)-1,2,3,5,6,7,8,9,10,11,13a,14,14a,15,16,16a-hexadecahydrocyclopropa[e]pyrrolo[1,2-a][1,4]diazacyclopentadecine-14a-carboxamide 
• 4091-39-8 3-chloro-2-butanone 
• 611-20-1 salicylonitrile 
• 54802-10-7 3-aminobenzofuran-2-carboxamide 

Relevant academic research and scientific papers

HCV PROTEASE INHIBITORS

This invention relates to compounds of Formula (I), (II), or (III) shown in the specification. These compounds can be used to treat hepatitis C virus infection.